miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells.
cancer stem cells
extracellular vesicles
glioblastoma
miRNAs
proteome
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
04 Aug 2022
04 Aug 2022
Historique:
received:
01
07
2022
revised:
27
07
2022
accepted:
28
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite available therapeutic interventions, it is very difficult to treat, and a cure is not yet available. The intra-tumoral GBM heterogeneity is a crucial factor contributing to poor clinical outcomes. GBM derives from a small heterogeneous population of cancer stem cells (CSCs). In cancer tissue, CSCs are concentrated within the so-called niches, where they progress from a slowly proliferating phase. CSCs, as most tumor cells, release extracellular vesicles (EVs) into the surrounding microenvironment. To explore the role of EVs in CSCs and GBM tumor cells, we investigated the miRNA and protein content of the small EVs (sEVs) secreted by two GBM-established cell lines and by GBM primary CSCs using omics analysis. Our data indicate that GBM-sEVs are selectively enriched for miRNAs that are known to display tumor suppressor activity, while their protein cargo is enriched for oncoproteins and tumor-associated proteins. Conversely, among the most up-regulated miRNAs in CSC-sEVs, we also found pro-tumor miRNAs and proteins related to stemness, cell proliferation, and apoptosis. Collectively, our findings support the hypothesis that sEVs selectively incorporate different miRNAs and proteins belonging both to fundamental processes (e.g., cell proliferation, cell death, stemness) as well as to more specialized ones (e.g., EMT, membrane docking, cell junction organization, ncRNA processing).
Identifiants
pubmed: 36009432
pii: biomedicines10081886
doi: 10.3390/biomedicines10081886
pmc: PMC9405730
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Italian Ministry for Education, University and Research
ID : Under the framework of the Flagship Project Interomics
Références
Nat Commun. 2019 Apr 16;10(1):1787
pubmed: 30992437
Oncotarget. 2015 Dec 1;6(38):40998-1017
pubmed: 26517510
Cancer Gene Ther. 2020 Jun;27(6):395-398
pubmed: 31477807
Mol Cell. 2021 Aug 19;81(16):3323-3338.e14
pubmed: 34352207
Cancers (Basel). 2020 Jun 19;12(6):
pubmed: 32575666
Biochemistry (Mosc). 2016 Sep;81(9):941-50
pubmed: 27682166
Nat Cell Biol. 2008 May;10(5):619-24
pubmed: 18425114
PLoS Negl Trop Dis. 2020 Oct 5;14(10):e0008586
pubmed: 33017416
Front Oncol. 2021 May 19;11:630417
pubmed: 34094911
J Immunother Cancer. 2021 Jun;9(6):
pubmed: 34083417
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Nature. 2017 Nov 9;551(7679):251-255
pubmed: 29072297
Cell Biosci. 2016 Oct 28;6:56
pubmed: 27800153
Nat Rev Clin Oncol. 2020 Apr;17(4):204-232
pubmed: 31792354
Biomedicines. 2020 Jul 16;8(7):
pubmed: 32708613
Nature. 2020 Jul;583(7817):638-643
pubmed: 32555463
Int J Cancer. 2015 Oct 1;137(7):1630-42
pubmed: 25802036
Nucleic Acids Res. 2020 Jan 8;48(D1):D148-D154
pubmed: 31647101
Nature. 2018 Jun;558(7711):605-609
pubmed: 29925953
J Proteome Res. 2019 Feb 1;18(2):623-632
pubmed: 30450911
Nature. 2019 Feb;566(7742):100-104
pubmed: 30700908
J Exp Clin Cancer Res. 2015 Apr 02;34:32
pubmed: 25886763
Cancer Cell Int. 2021 Nov 27;21(1):633
pubmed: 34838021
Am J Transl Res. 2017 Nov 15;9(11):4785-4806
pubmed: 29218080
Semin Cell Dev Biol. 2017 Jul;67:48-55
pubmed: 28104520
Nat Cell Biol. 2015 Feb;17(2):170-82
pubmed: 25580734
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Mol Neurobiol. 2019 Jun;56(6):4566-4581
pubmed: 30353492
J Biol Chem. 2022 Mar;298(3):101590
pubmed: 35033535
J Mol Histol. 2021 Jun;52(3):589-596
pubmed: 33725213
Nat Rev Mol Cell Biol. 2020 Oct;21(10):585-606
pubmed: 32457507
Cancers (Basel). 2020 Mar 20;12(3):
pubmed: 32244981
Mol Cell. 2018 Jul 19;71(2):244-255.e5
pubmed: 29983320
Oncogene. 2016 Apr 7;35(14):1785-96
pubmed: 26234676
Theranostics. 2021 Jan 1;11(4):1763-1779
pubmed: 33408780
Sci Rep. 2022 Jun 18;12(1):10278
pubmed: 35717510
BMC Genomics. 2011 Jan 26;12:64
pubmed: 21269452
Cancer Cell. 2012 Dec 11;22(6):765-80
pubmed: 23238013
Neurochem Int. 2014 May;71:1-7
pubmed: 24657832
Cell Rep. 2012 May 31;1(5):424-33
pubmed: 22768388
Oncogene. 2020 Nov;39(46):6990-7004
pubmed: 33077835
Expert Rev Proteomics. 2009 Jun;6(3):267-83
pubmed: 19489699
Nucleic Acids Res. 2021 Nov 18;49(20):11810-11822
pubmed: 34718722
PLoS Biol. 2019 Jun 14;17(6):e3000297
pubmed: 31199786
J Neuropathol Exp Neurol. 2016 Feb;75(2):134-47
pubmed: 26792897
Clin Cancer Res. 2013 Aug 15;19(16):4392-403
pubmed: 23804423
FASEB J. 2009 May;23(5):1541-57
pubmed: 19109410
Biomolecules. 2019 Aug 28;9(9):
pubmed: 31466382
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
J Clin Invest. 2022 Mar 15;132(6):
pubmed: 35133980
Oncotarget. 2017 Mar 14;8(11):17873-17886
pubmed: 28157712
Cells. 2019 Dec 30;9(1):
pubmed: 31906023
Nat Rev Cancer. 2020 Jun;20(6):303-322
pubmed: 32300195
Cancer Cell. 2013 Sep 9;24(3):318-30
pubmed: 24029231
J Neurooncol. 2017 Jan;131(2):233-244
pubmed: 27770278
JCI Insight. 2021 May 10;6(9):
pubmed: 33986188
Glia. 2018 Nov;66(11):2267-2278
pubmed: 29726599
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Proteomics Clin Appl. 2015 Apr;9(3-4):358-67
pubmed: 25684126
Genome Biol. 2021 Jan 28;22(1):51
pubmed: 33509238
Front Immunol. 2022 May 20;13:914236
pubmed: 35669791
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
J Biol Chem. 2018 Aug 17;293(33):12862-12876
pubmed: 29880640
Cell Death Dis. 2020 Jul 23;11(7):563
pubmed: 32703935
Front Mol Biosci. 2021 Sep 22;8:692130
pubmed: 34631793
Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8
pubmed: 27668386
Pharmaceutics. 2021 Jun 29;13(7):
pubmed: 34210109
Cancer Res. 2009 Apr 15;69(8):3472-81
pubmed: 19351838
RNA Biol. 2013 Aug;10(8):1333-44
pubmed: 23807490
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Cancer Lett. 2021 Jan 1;496:134-143
pubmed: 33022290
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33720050
Nat Cancer. 2021 Sep;2(9):932-949
pubmed: 35121864
RNA. 2017 Dec;23(12):1754-1769
pubmed: 28855326
Int J Mol Sci. 2020 Jun 07;21(11):
pubmed: 32517326
J Neuroinflammation. 2020 Apr 16;17(1):120
pubmed: 32299465
Theranostics. 2021 Sep 27;11(19):9687-9704
pubmed: 34646393
J Neurosurg. 2019 Aug 23;:1-9
pubmed: 31443071
Genes Dev. 2015 Jun 15;29(12):1203-17
pubmed: 26109046